Facebook

Tuberculosis

We are calling for the development of a point-of-care TB test and working to increase access to treatment for drug resistant TB by supporting the introduction of promising new medicines and tackling supply problems of older drugs.

23. March 2017.
|
WORLD TB DAY

Fewer than 5% of people in need are treated with new TB drugs, nearly four years after their approval

Companies and countries must take urgent action to increase access to these life-saving treatments.
Read more

Tuberculosis: The Issues

Cambodia © Sean Brokenshire/MSF

Learn about the issues MSF & others confront in the diagnosis and treatment of tuberculosis.

» Read more

Featured multimedia

XDR-TB patient successfully completes treatment
Late 2013, Elizabeth started treatment for multidrug-resistant tuberculosis (MDR-TB) at MSF’s Green House Clinic in Nairobi...

Tags: tuberculosis, XDR-TB, bedaquiline

↑ To top